Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001529510 | SCV000718975 | likely benign | not provided | 2021-04-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000622185 | SCV000735282 | likely benign | Cardiovascular phenotype | 2016-01-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000628820 | SCV000749727 | benign | Primary dilated cardiomyopathy | 2023-12-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003953033 | SCV004766994 | likely benign | TXNRD2-related condition | 2019-10-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001529510 | SCV001743088 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529510 | SCV001974516 | likely benign | not provided | no assertion criteria provided | clinical testing |